[Epithelial ovarian cancer: what is the consensus in 1995?].
We debate about a case report of epithelial ovarian cancer, the acknowledge therapeutic formalities and the outlook behaviors, now in progress. Indeed, the better definition high risks women of epithelial ovarian cancer, and the proving of new therapeutic formalities, will allow the improvement of survival rates.
Service de médecine oncologique, centre Henri-Becquerel, Rouen, 0rance.
B
B
Chevallier
P
P
Dessogne
D000970:Antineoplastic Agents / Q000008:administration & dosage; D018394:CA-125 Antigen / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D010052:Ovariectomy; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018394:CA-125 Antigen; D013629:Tamoxifen; D002945:Cisplatin
Cancer épithélial de l'ovaire: quel consensus en 1995?